Abstract:Tumor is one of the most serious threats for human being. Although many anti-tumor drugs are approved for clinical use, the treatment outcome is still modest because of the poor tumor targeting efficiency and low accumulation in tumor. Therefore, it is important to deliver anti-tumor drug into tumor efficiently, elevate drug concentration in tumor tissues and reduce the drug distribution in normal tissues. And it has been one of the most attractive directions of pharmaceutical academy and industry. Many kinds of strategies, especially various nanoparticulated drug delivery systems, have been developed to address the critical points of complex tumor microenvironment, which are partially or mostly satisfied for tumor treatment. In this paper, we carefully reviewed the novel targeting delivery strategies developed in recent years. The most powerful method is passive targeting delivery based on the enhanced permeability and retention(EPR) effect, and most commercial nanomedicines are based on the EPR effect. However, the high permeability and retention require different particle sizes, thus several kinds of size-changeable nanoparticles are developed, such as size reducible particles and assemble particles, to satisfy the controversial requirement for particle size and enhance both tumor retention and penetration. Surface charge reversible nanoparticles also shows a high efficiency because the anionic charge in blood circulation and normal organs decrease the unintended internalization. The charge can change into positive in tumor microenvironment, facilitating drug uptake by tumor cells. Additionally, tumor microenvironment responsive drug release is important to decrease drug side effect, and many strategies are developed, such as p H sensitive release and enzyme sensitive release. Except the responsive nanoparticles, shaping tumor microenvironment could attenuate the barriers in drug delivery, for example, decreasing tumor collagen intensity and normalizing tumor microvessels to decrease the internal fluid pressure. All these strategies could enhance the accumulation and penetration of nanoparticles into tumor, leading to a homogenous distribution of drugs in tumor. To enhance the internalization by specific cells, active targeting delivery strategies are developed. There were many surface markers, receptors or carriers overexpressed on specific kinds of cells, thus the corresponding ligands were utilized to mediate active targeting to certain cells, including tumor cells, cancer stem cells, tumor neovasculatures, tumor associated macrophages and other tumor stroma cells. Targeting more than one cell type may provide an improved antitumor effect. Although these passive and active targeting strategies all have promising outcome in the treatment of tumor, some shortages are still unaddressed, such as the specificity of responsive is not good enough, and the active targeting may be diminished by the protein corona. Thus more research is required to promote the drug delivery study.

Strategies of engineering nanomedicines for tumor retention

Strategies to improve tumor penetration of nanomedicines through nanoparticle design

Recent Advances in Nanostrategies Capable of Overcoming Biological Barriers for Tumor Management

Nano-engineering nanomedicines with customized functions for tumor treatment applications

“Smart” Nanocarriers: A New Paradigm for Tumor Targeting Drug Delivery Systems

Size Shrinkable Drug Delivery Nanosystems and Priming the Tumor Microenvironment for Deep Intratumoral Penetration of Nanoparticles

The progress and perspective of strategies to improve tumor penetration of nanomedicines

Nano‐Engineering Strategies for Tumor‐Specific Therapy

New Nanomaterials and Techniques for Tumor-targeted Systems

[The Development of Novel Tumor Targeting Delivery Strategy].

New Strategies in the Design of Nanomedicines to Oppose Uptake by the Mononuclear Phagocyte System and Enhance Cancer Therapeutic Efficacy

Strategies to prolong drug retention in solid tumors by aggregating Endo-CMC nanoparticles

Engineering Nanoparticles to Tackle Tumor Barriers.

Size-Tunable Strategies for a Tumor Targeted Drug Delivery System

Nanomedicine in cancer therapy

Engineering nanoparticles to tackle tumor barriers

Nanoparticles for tumor targeted therapies and their pharmacokinetics.

A Nanoparticle's Journey to the Tumor: Strategies to Overcome First-Pass Metabolism and Their Limitations

Recent Advances in Drug Delivery Systems for Enhancing Drug Penetration into Tumors

Nanomaterials in tumor immunotherapy: new strategies and challenges

Nanoparticle-Mediated Transcytosis in Tumor Drug Delivery: Mechanisms, Categories, and Novel Applications